ICOSLG and allergic asthma: It has been reported that activation of ICOS+ Tregs mediates allergic airway diseases, and targeting the ICOS/ICOS-L pathway may disrupt T follicular helper cell responses and ameliorate allergic asthma by disrupting the disease [33,34].